EUVIMEDOpdag EUVIMED
Open access · CC BY-NC 4.0

Neural substrates underlying distinct dual cognitive syndromes in Parkinson's disease

Kenji Yoshimura iD, Atsushi Shima iD, Daisuke Kambe, Koji Furukawa, Akira Nishida, Ikko Wada, Yusuke Sakato, Haruhi Sakamaki-Tsukita, Yuta Terada, Hodaka Yamakado, Yosuke Taruno, Etsuro Nakanishi and 8 more

European Journal of Neurology · 2025-01 · 32 (1)

DOI: 10.1111/ene.70022 ↗

At a glance

Journal article in European Journal of Neurology, published online on 2024-12-24. Written by Kenji Yoshimura and 19 co-authors. Institution: Department of Neurology, Kyoto University Graduate School of Medicine, Kyoto, Japan. Major MEDLINE topics: Parkinson Disease, Cognitive Dysfunction. Cited 10 times so far (Crossref); 43 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development, Japan Science and Technology Agency.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

A dual‐syndrome hypothesis, which states the cognitive impairments in Parkinson's disease (PD) are attributable to frontostriatal dopaminergic dysregulation and cortical disturbance—each associated with attention/executive and memory/visuospatial dysfunction, respectively—has been widely accepted. This multisystem contribution also underlies highly heterogeneous progression rate to dementia.

Methods

Nondemented PD patients who underwent [ 123 I]N‐ω‐fluoropropyl‐2β‐carbomethoxy‐3β‐(4‐iodophenyl) nortropane ([ 123 I]FP‐CIT) SPECT and neuropsychological examinations were enrolled. Patients who agreed to participate and age‐ and sex‐matched healthy controls (HCs) also underwent 7‐T MRI. Patients were classified as cognitively normal (PD‐CN) or mild cognitive impairment (PD‐MCI) following the level II criteria of Movement Disorder Society Guideline.

Results

A total of 155 patients (PD‐CN/PD‐MCI 74/81) were enrolled, whereas 76 patients (PD‐CN/PD‐MCI 35/41) and 56 HCs underwent 7 T‐MRI. The caudate [ 123 I]FP‐CIT uptake in PD was correlated with the performance of attention/working memory (trail‐making test [TMT]‐A and symbol digit modality test) and executive (TMT‐B) domains. In contrast, the regional cortical thickness in the left frontotemporal and right frontal lobes in PD was correlated with performance of memory (Hopkins verbal learning test‐revised delayed recall) and visuospatial (judgment of line orientation) domains. Moreover, compared to 37 HCs with a Montreal Cognitive Assessment score of >25, PD‐CN patients showed broad occipitoparietal cortical thinning.

Conclusions

We demonstrated distinctive impairments of dopaminergic frontostriatal deficits and cortical degeneration as neural bases for the dual‐syndrome hypothesis. Our findings suggest that occipitoparietal lobe thinning occurs at a cognitively normal stage, and additional frontotemporal lobe thinning underlies impairments in the memory and visuospatial domains at the PD‐MCI stage.

Subjects

MeSH terms (MEDLINE)

Parkinson DiseaseCognitive DysfunctionHumansMaleFemaleAgedMiddle AgedMagnetic Resonance ImagingTomography, Emission-Computed, Single-PhotonTropanesNeuropsychological TestsExecutive Function

Author keywords

7 T‐MRIParkinson's disease[123I]FP‐CIT SPECTmild cognitive impairmentsurface‐based morphometry

Substances

Tropanes2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane

Authors and institutions

  • Department of Neurology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Human Brain Research Center, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Department of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Department of Human Health Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan.

ORCID profiles: Kenji Yoshimura, Atsushi Shima, Nobukatsu Sawamoto

Funding

  • Japan Society for the Promotion of Science
  • Japan Agency for Medical Research and Development
  • Japan Science and Technology Agency

Cite

APA

Yoshimura, K., Shima, A., Kambe, D., Furukawa, K., Nishida, A., Wada, I., Sakato, Y., Sakamaki-Tsukita, H., Terada, Y., Yamakado, H., Taruno, Y., Nakanishi, E., Sawamura, M., Fujimoto, K., Fushimi, Y., Okada, T., Nakamoto, Y., Hanakawa, T., Takahashi, R., & Sawamoto, N. (2025). Neural substrates underlying distinct dual cognitive syndromes in Parkinson's disease. European Journal of Neurology, 32(1). https://doi.org/10.1111/ene.70022

Vancouver

Yoshimura K, Shima A, Kambe D, Furukawa K, Nishida A, Wada I, et al. Neural substrates underlying distinct dual cognitive syndromes in Parkinson's disease. European Journal of Neurology. 2025;32(1). doi:10.1111/ene.70022

BibTeX
@article{Yoshimura2025,
  author = {Yoshimura, Kenji and Shima, Atsushi and Kambe, Daisuke and Furukawa, Koji and Nishida, Akira and Wada, Ikko and Sakato, Yusuke and Sakamaki-Tsukita, Haruhi and Terada, Yuta and Yamakado, Hodaka and Taruno, Yosuke and Nakanishi, Etsuro and Sawamura, Masanori and Fujimoto, Koji and Fushimi, Yasutaka and Okada, Tomohisa and Nakamoto, Yuji and Hanakawa, Takashi and Takahashi, Ryosuke and Sawamoto, Nobukatsu},
  title = {Neural substrates underlying distinct dual cognitive syndromes in Parkinson's disease},
  journal = {European Journal of Neurology},
  year = {2025},
  volume = {32},
  number = {1},
  doi = {10.1111/ene.70022}
}
Start for free →